Merck COVID-19 pill provokes worldwide call for access

International health factions states that the launching of the Merck & Co’s antiviral pill to treat COVID-19 has increased its demand worldwidely. As only 5% of Africa’s population is immunized, it has created an urgent need for therapeutics to keep people out of hospitals. On the other hand, almost 70% inoculation rate is seen in most wealthy nations.

Share this post